Related references
Note: Only part of the references are listed.Identification of heat shock protein 60 as the regulator of the hypoxia-inducible factor subunit HIF-1α
Hyun Seung Ban et al.
PURE AND APPLIED CHEMISTRY (2012)
Discovery of ortho-Carborane-Conjugated Triazines as Selective Topoisomerase I/II Inhibitors
Hiroyuki Nakamura et al.
AUSTRALIAN JOURNAL OF CHEMISTRY (2011)
Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies
Matthias Scholz et al.
CHEMICAL REVIEWS (2011)
Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004-2010)
Hyun Seung Ban et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors
Kazuki Shimizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Discovery of Carboranes as Inducers of 20S Proteasome Activity
Hyun Seung Ban et al.
CHEMMEDCHEM (2010)
Adenosine and 2′-Deoxyadenosine Modified with Boron Cluster Pharmacophores as New Classes of Human Blood Platelet Function Modulators
Katarzyna Bednarska et al.
CHEMMEDCHEM (2010)
Identification of HSP60 as a Primary Target of o-Carboranylphenoxyacetanilide, an HIF-1α Inhibitor
Hyun Seung Ban et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Synthesis and biological evaluation of p-carborane bisphenols and their derivatives: Structure-activity relationship for estrogenic activity
Takumi Ogawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors
Hiroyuki Nakamura et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Discovery of boron-conjugated 4-anilinoquinazoline as a prolonged inhibitor of EGFR tyrosine kinase
Hyun Seung Ban et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2009)
Nucleophilic Addition of Organozinc Reagents to 2-Sulfonyl Cyclic Ethers: Stereoselective Synthesis of Manassantins A and B
Hyoungsu Kim et al.
ORGANIC LETTERS (2009)
A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1α
Shan Hua Li et al.
MOLECULAR CANCER THERAPEUTICS (2008)
HYPOXIA AND METABOLISM SERIES - TIMELINE The impact of O2 availability on human cancer
Jessica A. Bertout et al.
NATURE REVIEWS CANCER (2008)
Hypoxia and cancer
M. Christiane Brahimi-Horn et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores
Richard L. Julius et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
Total synthesis and stereochemical confirmation of manassantin A, B, and B1
Stephen Hanessian et al.
ORGANIC LETTERS (2006)
Synthesis and biological evaluation of boronic acid containing cis-stilbenes as apoptotic tubulin polymerzation inhibitors
Hiroyuki Nakamura et al.
CHEMMEDCHEM (2006)
Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1)
DG Nagle et al.
CURRENT DRUG TARGETS (2006)
Saururus cernuus lignans -: Potent small molecule inhibitors of hypoxia-inducible factor-1
CF Hossain et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Manassantin A and B isolated from Saururus chinensis inhibit TNF-alpha-induced cell adhesion molecule expression of human umbilical vein endothelial cells
OE Kwon et al.
ARCHIVES OF PHARMACAL RESEARCH (2005)
Molecular-targeted antitumor agents:: The Saururus cernuus dineolignans manassantin B and 4-O-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1
TW Hodges et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Design, synthesis, and biological evaluation of aminoboronic acids as growth-factor receptor inhibitors of EGFR and VEGFR-1 tyrosine kinases
T Asano et al.
CHEMBIOCHEM (2004)
HIF-1 as a target for drug development
A Giaccia et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Cellular adaptation to hypoxia:: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression
RH Wenger
FASEB JOURNAL (2002)
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
A Giatromanolaki et al.
BRITISH JOURNAL OF CANCER (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Potent estrogen agonists based on carborane as a hydrophobic skeletal structure - A new medicinal application of boron clusters
Y Endo et al.
CHEMISTRY & BIOLOGY (2001)
Levels of hypoxia-inducible factor-1α during breast carcinogenesis
R Bos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
